Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000320017-23-000011
Filing Date
2023-03-30
Accepted
2023-03-30 16:09:20
Documents
205
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K clbs-20221231.htm   iXBRL 10-K 1704112
2 EX-10.1 ex101to10-k20222131.htm EX-10.1 12242
3 EX-10.2 ex102-lisatatherapeutics.htm EX-10.2 78907
4 EX-10.3 ex1032018equityincentive.htm EX-10.3 239201
5 EX-10.4 ex104-2015equitycompensa.htm EX-10.4 92836
6 EX-10.5 ex105-amendedrestated200.htm EX-10.5 71138
7 EX-10.25 ex1025clawbackpolicy.htm EX-10.25 30566
8 EX-14.1 ex14110-k20221231.htm EX-14.1 26887
9 EX-21.1 ex211to10k20221231.htm EX-21.1 10477
10 EX-23.1 exh2312022.htm EX-23.1 3187
11 EX-31.1 clbs-ex311_20221231xq4.htm EX-31.1 9067
12 EX-32 clbs-ex32_20221231.htm EX-32 6172
18 clbs-20221231_g1.jpg GRAPHIC 158919
19 ex102-lisatatherapeutics001.jpg GRAPHIC 286232
20 ex102-lisatatherapeutics002.jpg GRAPHIC 270564
21 ex102-lisatatherapeutics003.jpg GRAPHIC 290676
22 ex102-lisatatherapeutics004.jpg GRAPHIC 317432
23 ex102-lisatatherapeutics005.jpg GRAPHIC 335694
24 ex102-lisatatherapeutics006.jpg GRAPHIC 288553
25 ex102-lisatatherapeutics007.jpg GRAPHIC 367936
26 ex102-lisatatherapeutics008.jpg GRAPHIC 306038
27 ex102-lisatatherapeutics009.jpg GRAPHIC 337610
28 ex102-lisatatherapeutics010.jpg GRAPHIC 309079
29 ex102-lisatatherapeutics011.jpg GRAPHIC 360482
30 ex102-lisatatherapeutics012.jpg GRAPHIC 328738
31 GRAPHIC ex102-lisatatherapeutics013.jpg GRAPHIC 301470
32 GRAPHIC ex102-lisatatherapeutics014.jpg GRAPHIC 352501
33 GRAPHIC ex102-lisatatherapeutics015.jpg GRAPHIC 192090
34 ex1032018equityincentive001.jpg GRAPHIC 198822
35 ex1032018equityincentive002.jpg GRAPHIC 244766
36 ex1032018equityincentive003.jpg GRAPHIC 212750
37 ex1032018equityincentive004.jpg GRAPHIC 218878
38 ex1032018equityincentive005.jpg GRAPHIC 228499
39 ex1032018equityincentive006.jpg GRAPHIC 236471
40 ex1032018equityincentive007.jpg GRAPHIC 247185
41 ex1032018equityincentive008.jpg GRAPHIC 274131
42 ex1032018equityincentive009.jpg GRAPHIC 236683
43 ex1032018equityincentive010.jpg GRAPHIC 270172
44 ex1032018equityincentive011.jpg GRAPHIC 317019
45 ex1032018equityincentive012.jpg GRAPHIC 207277
46 ex1032018equityincentive013.jpg GRAPHIC 294116
47 ex1032018equityincentive014.jpg GRAPHIC 290370
48 ex1032018equityincentive015.jpg GRAPHIC 272520
49 ex1032018equityincentive016.jpg GRAPHIC 257388
50 ex1032018equityincentive017.jpg GRAPHIC 287007
51 ex1032018equityincentive018.jpg GRAPHIC 230618
52 ex1032018equityincentive019.jpg GRAPHIC 241659
53 ex1032018equityincentive020.jpg GRAPHIC 221205
54 ex1032018equityincentive021.jpg GRAPHIC 235385
55 ex1032018equityincentive022.jpg GRAPHIC 319163
56 ex1032018equityincentive023.jpg GRAPHIC 229899
57 ex1032018equityincentive024.jpg GRAPHIC 298208
58 ex1032018equityincentive025.jpg GRAPHIC 276533
59 ex1032018equityincentive026.jpg GRAPHIC 300385
60 ex1032018equityincentive027.jpg GRAPHIC 298698
61 ex1032018equityincentive028.jpg GRAPHIC 317500
62 ex1032018equityincentive029.jpg GRAPHIC 293768
63 ex1032018equityincentive030.jpg GRAPHIC 362596
64 ex1032018equityincentive031.jpg GRAPHIC 298695
65 ex1032018equityincentive032.jpg GRAPHIC 343151
66 ex1032018equityincentive033.jpg GRAPHIC 329521
67 ex1032018equityincentive034.jpg GRAPHIC 336405
68 ex1032018equityincentive035.jpg GRAPHIC 311636
69 ex1032018equityincentive036.jpg GRAPHIC 301733
70 ex1032018equityincentive037.jpg GRAPHIC 337475
71 ex1032018equityincentive038.jpg GRAPHIC 297364
72 ex1032018equityincentive039.jpg GRAPHIC 246741
73 ex1032018equityincentive040.jpg GRAPHIC 275430
74 ex1032018equityincentive041.jpg GRAPHIC 277395
75 ex1032018equityincentive042.jpg GRAPHIC 274961
76 ex1032018equityincentive043.jpg GRAPHIC 273255
77 ex1032018equityincentive044.jpg GRAPHIC 307307
78 ex1032018equityincentive045.jpg GRAPHIC 290037
79 ex1032018equityincentive046.jpg GRAPHIC 332971
80 ex1032018equityincentive047.jpg GRAPHIC 280360
81 ex1032018equityincentive048.jpg GRAPHIC 344588
82 ex1032018equityincentive049.jpg GRAPHIC 279756
83 ex1032018equityincentive050.jpg GRAPHIC 338092
84 ex1032018equityincentive051.jpg GRAPHIC 285125
85 ex1032018equityincentive052.jpg GRAPHIC 269655
86 ex1032018equityincentive053.jpg GRAPHIC 295603
87 ex1032018equityincentive054.jpg GRAPHIC 355860
88 ex104-2015equitycompensa001.jpg GRAPHIC 249891
89 ex104-2015equitycompensa002.jpg GRAPHIC 235993
90 ex104-2015equitycompensa003.jpg GRAPHIC 209186
91 ex104-2015equitycompensa004.jpg GRAPHIC 266534
92 ex104-2015equitycompensa005.jpg GRAPHIC 237803
93 ex104-2015equitycompensa006.jpg GRAPHIC 235407
94 ex104-2015equitycompensa007.jpg GRAPHIC 283665
95 ex104-2015equitycompensa008.jpg GRAPHIC 294113
96 ex104-2015equitycompensa009.jpg GRAPHIC 256270
97 ex104-2015equitycompensa010.jpg GRAPHIC 361936
98 ex104-2015equitycompensa011.jpg GRAPHIC 235090
99 ex104-2015equitycompensa012.jpg GRAPHIC 312629
100 ex104-2015equitycompensa013.jpg GRAPHIC 314498
101 ex104-2015equitycompensa014.jpg GRAPHIC 277455
102 ex104-2015equitycompensa015.jpg GRAPHIC 310851
103 ex104-2015equitycompensa016.jpg GRAPHIC 296534
104 ex104-2015equitycompensa017.jpg GRAPHIC 288061
105 ex104-2015equitycompensa018.jpg GRAPHIC 279812
106 ex104-2015equitycompensa019.jpg GRAPHIC 316598
107 ex104-2015equitycompensa020.jpg GRAPHIC 315821
108 ex104-2015equitycompensa021.jpg GRAPHIC 150942
109 ex104-2015equitycompensa022.jpg GRAPHIC 221824
110 ex104-2015equitycompensa023.jpg GRAPHIC 229249
111 ex105-amendedrestated200001.jpg GRAPHIC 266083
112 ex105-amendedrestated200002.jpg GRAPHIC 245348
113 ex105-amendedrestated200003.jpg GRAPHIC 196855
114 ex105-amendedrestated200004.jpg GRAPHIC 245711
115 ex105-amendedrestated200005.jpg GRAPHIC 241932
116 ex105-amendedrestated200006.jpg GRAPHIC 311124
117 ex105-amendedrestated200007.jpg GRAPHIC 259946
118 ex105-amendedrestated200008.jpg GRAPHIC 345286
119 ex105-amendedrestated200009.jpg GRAPHIC 263457
120 ex105-amendedrestated200010.jpg GRAPHIC 288440
121 ex105-amendedrestated200011.jpg GRAPHIC 291862
122 ex105-amendedrestated200012.jpg GRAPHIC 284876
123 ex105-amendedrestated200013.jpg GRAPHIC 321591
124 ex105-amendedrestated200014.jpg GRAPHIC 268581
125 ex105-amendedrestated200015.jpg GRAPHIC 254068
126 ex105-amendedrestated200016.jpg GRAPHIC 252728
127 ex105-amendedrestated200017.jpg GRAPHIC 222644
128 ex105-amendedrestated200018.jpg GRAPHIC 228094
129 image.jpg GRAPHIC 21441
  Complete submission text file 0000320017-23-000011.txt   51182128

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clbs-20221231.xsd EX-101.SCH 58165
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clbs-20221231_cal.xml EX-101.CAL 83260
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clbs-20221231_def.xml EX-101.DEF 182255
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clbs-20221231_lab.xml EX-101.LAB 723226
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clbs-20221231_pre.xml EX-101.PRE 440176
199 EXTRACTED XBRL INSTANCE DOCUMENT clbs-20221231_htm.xml XML 964444
Mailing Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD SECOND FLOOR BASKING RIDGE NJ 07920 908-229-2590
LISATA THERAPEUTICS, INC. (Filer) CIK: 0000320017 (see all company filings)

EIN.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33650 | Film No.: 23780764
SIC: 8090 Services-Misc Health & Allied Services, NEC